Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
8.46
-0.25 (-2.87%)
Mar 14, 2025, 12:21 PM EDT - Market open
DAWN Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 14, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 858 | 1,278 | 1,271 | 1,583 | 1,044 | - | |
| Market Cap Growth | 0.54% | 0.54% | -19.71% | 51.68% | - | - | |
| Enterprise Value | 353 | 722 | 866 | 1,209 | 747 | - | |
| Last Close Price | 8.70 | 12.67 | 14.60 | 21.52 | 16.85 | - | |
| PS Ratio | 6.18 | 9.74 | - | - | - | - | |
| PB Ratio | 1.75 | 2.54 | 3.67 | 4.77 | 3.71 | - | |
| P/TBV Ratio | 2.62 | 2.62 | 3.67 | 4.77 | 3.71 | - | |
| EV/Sales Ratio | 2.69 | 5.50 | - | - | - | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Asset Turnover | 0.27 | 0.27 | - | - | - | - | |
| Quick Ratio | 7.43 | 7.43 | 12.42 | 20.60 | 32.84 | 21.91 | |
| Current Ratio | 7.66 | 7.66 | 12.72 | 20.94 | 33.43 | 22.58 | |
| Return on Equity (ROE) | -22.49% | -22.49% | -55.68% | -46.37% | -44.83% | -127.49% | |
| Return on Assets (ROA) | -27.67% | -27.67% | -35.52% | -28.74% | -27.10% | -23.60% | |
| Return on Capital (ROIC) | -31.13% | -31.13% | -37.89% | -29.90% | -27.96% | -24.90% | |
| Earnings Yield | -10.83% | -7.47% | -14.87% | -8.98% | -6.77% | - | |
| FCF Yield | -9.10% | -6.28% | -11.57% | -6.94% | -4.65% | - | |
| Buyback Yield / Dilution | -16.87% | -16.87% | -21.85% | -77.13% | -568.42% | 6.67% | |
| Total Shareholder Return | -16.87% | -16.87% | -21.85% | -77.13% | -568.42% | 6.67% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.